Official blog
Compliance-aware guides and brand updates for adult consumers.
Page 24 of 35 / 832 articles
The FDA has the authority to mandate that all cigarettes sold in the US contain only minimally addictive levels of nicotine. The policy has bipartisan support and strong scientific rationale. It also raises questions about black markets, unintended consequences, and consumer autonomy.
New Zealand's 'smoke-free generation' law—banning cigarette sales to anyone born after 2008—was the most ambitious tobacco control policy ever enacted. Then a change of government repealed it. The experiment in generational prohibition reveals the limits of legislative ambition.
Swedish snus—a moist oral tobacco product—has driven Sweden's smoking rate below 5%, the lowest in Europe. Swedish men have Europe's lowest lung cancer mortality. And snus is banned in every EU country except Sweden. How did the evidence get so thoroughly ignored?
America tried banning alcohol in 1920. It ended in 1933, after thirteen years of black markets, organized crime, and public disillusionment. A century later, nicotine regulators are repeating history—and they seem not to have read it.
Long after nicotine receptors have downregulated and withdrawal has subsided, many ex-smokers still feel the phantom cigarette—the muscle memory of the hand-to-mouth ritual, the absence of the object between the fingers. Addiction lives in the body, not just the brain.
Smokers who quit gain an average of 4-5 kilograms in the first year. For many smokers—particularly women—the fear of weight gain is a more powerful deterrent to quitting than the fear of lung cancer. Addressing this barrier requires honesty, not reassurance.
Proponents and opponents of nicotine harm reduction cite the same scientific literature and reach opposite conclusions. The disagreement is not about the data—it's about what kind of evidence should count, and who gets to decide.
In 2015, a small startup called Juul introduced a nicotine formulation that would transform the vaping industry. Nicotine salts—created by adding benzoic acid to freebase nicotine—delivered a smoother, faster-acting experience. The chemistry was simple. The consequences were not.
IQOS—Philip Morris International's heated tobacco device—was supposed to be the centerpiece of the company's smoke-free transformation. A decade and billions of dollars later, the verdict is still out: is heated tobacco the future, or an expensive detour?
Emerging research suggests that the trillions of bacteria living in the human gut play a role in nicotine metabolism, craving intensity, and cessation success. The frontier of smoking cessation may run through the digestive tract.
As smoking rates plummet in high-income countries, they are rising—or declining much more slowly—across much of Africa, Asia, and the Middle East. The global cigarette epidemic is not ending. It's relocating.
Traditional cigarette advertising has been banned for decades in most countries. But on TikTok, Instagram, and YouTube, nicotine products—particularly flavored vapes and pouches—are reaching audiences that regulation was designed to protect, through channels that regulation never anticipated.
The WHO Framework Convention on Tobacco Control, adopted in 2003 and now ratified by 182 countries, is the legal backbone of global tobacco control. Two decades on, its record is mixed—and the debates it suppressed are re-emerging with new urgency.
Tobacco taxation is the single most effective policy tool for reducing smoking. But when taxes rise too high, too fast, or without complementary policies, they create black markets, regressive burdens, and political backlash that can undo decades of progress.
Anti-smoking stigma is intended to motivate quitting. But a growing body of evidence suggests it does the opposite—increasing stress, reducing self-efficacy, delaying quit attempts, and driving smokers away from the healthcare system they need.
The majority of smokers who try to quit attempt it without any assistance—no medication, no counseling, no nicotine replacement. The method has an estimated success rate of 3-5%. So why does 'going cold turkey' remain the default strategy?
Public health agencies have spent decades telling the public that 'there is no safe tobacco product.' That message saved millions of lives. It also makes it nearly impossible to communicate the truth about safer nicotine products without undermining the original message.
As disposable vapes face environmental backlash and potential bans, a quiet resurgence of open-system vaping—refillable tanks, rebuildable coils, custom mods—is reshaping the enthusiast market. The future of vaping may look more like its past.
Nicotine pouches—tobacco-free, spit-free, and discreet—have gone from a Scandinavian niche to the fastest-growing segment of the nicotine industry. The major cigarette companies are betting billions that pouches, not vapes, are their smoke-free future.
Nicotine is among the most stigmatized molecules in pharmacology—associated, in the public imagination, with cancer, addiction, and death. But the association confuses the drug with its most common delivery mechanism. Understanding the difference is the key to rational policy.
Despite decades of regulation, taxation, public education, and the rise of alternatives, over one billion people still smoke combustible cigarettes. The persistence of the cigarette is not a mystery—but the explanations challenge every comfortable narrative in tobacco control.
Adolescent nicotine exposure affects the developing brain in ways that adult exposure doesn't. The science is clear about the risks—but the policy implications are more contested than either side of the youth vaping debate acknowledges.
As global cigarette consumption declines, millions of smallholder tobacco farmers—concentrated in low-income countries—face an economic transition that nobody is funding, coordinating, or even acknowledging at scale.
FDA's Premarket Tobacco Product Application process was designed to bring order to the vaping industry. Instead, it created a two-tier market: a handful of authorized products from large corporations, and a vast, thriving underground of everything else.
Products
Select a product to view details, highlights, and technical specifications.
